RSV Disease Burden and Nirsevimab Effectiveness in Young Children
This case-control study examines data from 7 academic pediatric medical centers to compare the epidemiology and disease burden of RSV-associated acute respiratory illness among children during the 2023-2024 season with 3 prepandemic seasons, estimate the effectiveness of nirsevimab, and compare…